Aktuelles zum Morbus Perthes

Zusammenfassung

Beim Morbus Perthes, der juvenilen Hüftkopfnekrose, kommt es zur Verminderung oder Unterbrechung der Blutversorgung der Epiphyse des Femurkopfes. Über die Ätiologie besteht bislang keine Einigkeit, systemische wie lokale Faktoren werden diskutiert. Die Erkrankung verläuft in verschiedenen Stadien. Die Diagnose kann in der Regel mittels konventioneller Röntgenaufnahmen gestellt werden. Das heute allgemein anerkannte therapeutische Prinzip besteht in dem Erhalt des Containments. Dies kann in Abhängigkeit von dem Schweregrad durch konservative Maßnahmen, häufig aber nur durch operative Eingriffe, erzielt werden. Die Langzeitprognose ist im Wesentlichen abhängig von der Sphärizität und Kongruenz zwischen Hüftkopf und Pfanne nach Ausheilung.

Summary

Perthes disease is characterized by a temporarily reduced blood supply of the femoral epiphysis resulting in femoral head necrosis. Concerning aetiology many systemic and locals factors are discussed. The course of the disease is characterized by defined stages. The diagnosis is usually made by X-ray. The widely accepted treatment concept is described by the „containment“ principle. Depending on the severity of the disease this may be achieved by conservative and/or surgical procedures. The longterm prognosis is dependent on the sphericity and congruency of the femoral head and the acetabulum in the final stage.

Schlüsselwörter

M. Perthes - Hüftkopf - Containment

Keywords

Perthes disease - head of the femur - containment

• Literatur

• 1 Aksoy MC, Caglar O, Yazici M, Alpaslan AM. Comparison between braced and non-braced Legg-Calvé-Perthes disease patients: a radiological outcome study. J Pediatr Orthop B 2004; 13: 153-7.
• 2 Bassett GS, Appel DM, Wintersteen VG, Tolo VT. Measurement of femoral head microcirculation by Laser Doppler Flowmetry. J Pediatr Orthop 1991; 11: 307-13.
• 3 Burwell RG, Vernon CL, Dangerfield PH, Kristmundsdottir F. Raised somatomedin activity in the serum of young boys with Perthes’ disease revealed by bioassay. A disease of growth transition?. Clin Orthop 1986; 209: 129-38.
• 4 Calvé J. Sur une forme particulière de pseudocoxalgie greffée sur déformations charactéristiques de l’extremité supérieure du fémur. Rev Chir 1910; 42: 54.
• 5 Catterall A. The natural history of Perthes disease. J Bone Joint Surg 1971; 53 B: 37-53.
• 6 Chiari K, Frank W. Veränderungen des Prothrombinspiegels bei M. Perthes. Z Orthop 1953; 83: 275-8.
• 7 Chung SMK, Ralston EL. Necrosis of the femoral head associated with sickle-cell anaemia and its genetic variants. J Bone Joint Surg 1969; 51A: 33-58.
• 8 Cooperman DR, Stuhlberg SD. Ambulatory containment treatment in Perthes disease. Clin Orthop 1986; 203: 289-300.
• 9 De Camargo FP, de Godoy RM. Angiography in Perthes disease. Clin Orthop 1984; 191: 216-20.
• 10 Engelhardt P. Das Risiko der sekundären Coxarthrose nach Hüftluxation, Morbus Perthes und Epiphyseolysis capitis femoris. Stuttgart, New York: Thieme; 1988
• 11 Exner G, Schreiber A. Wachstumsretardierung und Aufholwachstum bei Morbus Perthes. Z Orthop 1986; 124: 192-5.
• 12 Ferguson Jr AB. Segmental vascular changes in the femoral head in children and adults. Clin Orthop 1985; 200: 291-8.
• 13 Fisher RL. An epidemiological study of Legg-Perthes disease. J Bone Joint Surg 1972; 54A: 769-78.
• 14 Glueck C, Crawford A, Roy D. et al. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg 1996; 78A: 3-13.
• 15 Green NE, Griffin PP. Intraosseous venous pressure in Legg-Perthes disease. J Bone Joint Surg 1982; 64A: 666-71.
• 16 Hall AJ, Barker DJP, Dangerfield PH. et al. Small feet and Perthes’ disease. J Bone Joint Surg 1988; 70B: 611-13.
• 17 Hall AJ, Barker DJP, Lawton D. The social origins of Perthes’ disease of the hip. Paediatr Perinat Epidemiol 1990; 4: 64-70.
• 18 Harrison MHM, Turner MH, Jacobs P. Skeletal immaturity in Perthes disease. J Bone Joint Surg 1976; 58B: 37-40.
• 19 Hayek S, Kenet G, Lubetsky A. et al. Does thrombophilia play an aetiological role in Legg-Calvé-Perthes disease?. J Bone Joint Surg Br 1999; 81: 686-90.
• 20 Hefti F, Clarke NMP. The management of Legg-Calvé-Perthes disease: is there a consensus?. J Child Orthop 2007; 1: 19-25.
• 21 Heppenstall RB, Halston EL, Chung SK, Wurzel HA. Studies on the etiology of Legg-Calvé-Perthes. Ed Excerpta medica Amsterdam: Orthopedic Surgery and Traumatology; 1973
• 22 Herring JA. Current concepts review: the treatment of Legg-Calvé-Perthes-disease. J Bone Joint Surg 1994; 76A: 448-58.
• 23 Herring JA, Neustadt JB, William JJ. et al. The lateral pillar classification of Legg-Calvé-Perthes disease. J Pediatr Orthop 1992; 12: 143-50.
• 24 Hresko MT, McDougall PA, Gorlin JB. et al. Prospective reevaluation of the association between thrombotic diathesis and Legg-Perthes disease. J Bone Joint Surg 2002; 84: 1613-8.
• 25 Imhäuser G. Behandlung der Perthes’schen Erkrankung mit Fixierung in Entlastungsstellung (17-jährige Erfahrungen). Z Orthop 1970; 107: 553-8.
• 26 Jonsäter S. Coxa plana, a histopathologic and arthrografic study. Acta Orthop Scand Suppl 1953; 6: 5-98.
• 27 Joseph B. Serum immunoglobulin in Perthes’ disease. J Bone Joint Surg 1991; 73B: 509-10.
• 28 Joseph B, Rao N, Mulpuri K. et al. How does a femoral varus osteotomy alter the natural evolution of Perthes’ disease. J Pediatr Orthop B 2005; 14: 10-15.
• 29 Kallio P, Ryöppy S, Kunnamo I. Hyperpressure in juvenile hip disease. Acta Orthop Scand 1985; 56: 211-4.
• 30 Kallio P, Ryöppy S, Kunnamo I. Transient synovitis and Perthes’ disease. J Bone Joint Surg Br 1986; 68: 808-11.
• 31 Kamegaya M, Moriya H, Tsuchiya K. et al. Arthrography of early Perthes’ disease. Swelling of the ligamentum teres as a cause of subluxation. J Bone Joint Surg 1989; 71B: 413-7.
• 32 Katz JF, Siffert TS. Skeletal maturity in Legg-Clavé-Perthes disease. Int Orthop 1977; 1: 227-30.
• 33 Kealey WDC, Lappin KJ, Leslie H. et al. Endocrine profile and physical stature of children with Perthes disease. J Pediatr Orthop 2004; 2: 161-6.
• 34 Kitsugi T, Kasahara Y, Seto Y, Komai S. Normal somatomedin-C activity masured by radioimmunoassay in Perthes’ disease. Clin Orthop 1989; 244: 217-21.
• 35 Konermann W, de Pellegrin M. Die Differentialdiagnose des kindlichen Hüftschmerzes im Sonogramm. Coxitis fugax, Morbus Legg-Calvé-Perthes, Epiphyseolysis capitis femoris. Orthopäde 1993; 22: 280-7.
• 36 Krauspe R, Raab P. Morbus Perthes. Orthopäde 1997; 26: 289-302.
• 37 Legg AT. An obscure affection of the hip-joint. Boston Med Surg J 1910; 162: 202-3.
• 38 Lopez-Franco M, Gonzales-Moran G, De Lucas JC. et al. Legg-Perthes disease and heritable thrombophilia. J Pediatr Orthop 2005; 25: 456-9.
• 39 Maurer HJ, Skandfer B. Morbus Perthes – eine röntgenologisch-klinische Studie. Z Orthop 1978; 116: 240-7.
• 40 Mose K, Hjorth L, Ulfeldt M. et al. Legg-Calvé-Perthes disease; the late occurence of coxarthrosis. Acta Orthop Scand Suppl 1977; 169: 1-39.
• 41 Motokawa S. The effect of serum factors on skeletal growth in Perthes disease. Nippon Seikeigeka Gakkai Zasshi 1990; 64: 790-7.
• 42 Neidel J, Zander D, Hackenbroch MH. Low plasma levels of insulin-like growth factor I in Perthes disease. A controlled study of 59 consecutive children. Acta Orthop Scand 1992; 63: 393-8.
• 43 Neidel J, Zander D, Hackenbroch MH. No physiologic age-related increase of circulating somatomedin-C during early stage of Perthes’ disease: a longitudinal study in 21 boys. Arch Orthop Trauma Surg 1992; 111: 171-3.
• 44 Perthes GC. Über die Arthritis deformans iuvenilis. Dtsch Chir 1910; 107: 111-59.
• 45 Ranner G, Fotter R, Linhart W, Ebner F. Radiologische Diagnostik des Morbus Perthes. Radiologe 1994; 34: 21-9.
• 46 Rayner PHW, Schwalbe SL, Hall DJ. An assessment of endocrine function in boys with Perthes’ disease. Clin Orthop 1986; 209: 124-8.
• 47 Salter RB, Hansson G, Thompson GH. Innominate osteotomy in the management of residual congenital subluxation of the hip in young adults. Clin Orthop 1984; 182: 53-68.
• 48 Salter RB, Thompson GH. Legg-Calve-Perthes disease. The prognostic significance of the subchondral fracture and a two-group classification of the femoral head involvement. J Bone Joint Surg 1984; 66A: 479-89.
• 49 Schulitz KP, Dustmann HO. Morbus Perthes. 2. ed.. Berlin, Heidelberg: Springer; 1998
• 50 Schwarz N, Leixnering M, Hopf R, Jantsch S. Pressure volume ratio in human cadaver hip joints. Arch Orthop Trauma Surg 1988; 107: 322-5.
• 51 Shang-li L, Ho TC. The role of venous hypertension in the pathogenesis of Legg-Perthes disease. J Bone Joint Surg 1991; 73A: 194-200.
• 52 Tanaka H, Tamura K, Takano K. et al. Serum somatomedin A in Perthes’ disease. Acta Orthop Scand 1984; 55: 135-140.
• 53 Thompson SK, Woodrow JC. HLA antigens in Perthes’ disease. J Bone Joint Surg 1981; 63B: 278-9.
• 54 Vegter J, Lubsen CC. Fractional necrosis of the femoral head epiphysis after transient increase in joint pressure. An experimental study in iuvenile rabbits. J Bone Joint Surg 1987; 69B: 530-5.
• 55 Waldenström H. Coxa plana, Osteochondritis deformans coxae. Zentralblatt Chir 1920; 47: 539.
• 56 Westhoff B, Krauspe R, Kalke A. et al. Urinary excretion of deoxypyridinoline in Perthes’ disease: a prospective, controlled comparative study in 83 children. J Bone Joint Surg Br 2006; 88: 967-71.
• 57 Westhoff B, Petermann A, Hirsch MA. et al. Computerized gait analysis in Legg Calvé Perthes disease – analysis of the frontal plane. Gait Posture 2006; 24: 196-202.
• 58 Wild A, Westhoff B, Raab P, Krauspe R. Die nichtoperative Therapie des Morbus Perthes. Orthopäde 2003; 32: 139-45.